within Pharmacolibrary.Drugs.ATC.A;

model A11CC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dihydrotachysterol is a synthetic vitamin D analog formerly used in the treatment of hypocalcemia, such as that caused by hypoparathyroidism or renal osteodystrophy. It is no longer commonly used today due to the availability of newer vitamin D analogs and concerns regarding toxicity.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic values for oral administration in adults; no literature references with specific human PK data available.</p><h4>References</h4><ol><li><p>Koytchev, R, et al., &amp; Kirkov, V (1994). Differences in the bioavailability of dihydrotachysterol preparations. <i>European journal of clinical pharmacology</i> 47(1) 81–84. DOI:<a href=&quot;https://doi.org/10.1007/BF00193484&quot;>10.1007/BF00193484</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7988630/&quot;>https://pubmed.ncbi.nlm.nih.gov/7988630</a></p></li><li><p>Ahmed, KY, et al., &amp; Moorhead, JF (1976). Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. <i>Lancet (London, England)</i> 2(7983) 439–442. DOI:<a href=&quot;https://doi.org/10.1016/s0140-6736(76)92526-5&quot;>10.1016/s0140-6736(76)92526-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/73742/&quot;>https://pubmed.ncbi.nlm.nih.gov/73742</a></p></li><li><p>Qaw, F, et al., &amp; Jones, G (1992). The metabolism of dihydrotachysterols: renal side chain and non-renal nuclear hydroxylations in vivo and in vitro. <i>The Journal of steroid biochemistry and molecular biology</i> 41(3-8) 859–870. DOI:<a href=&quot;https://doi.org/10.1016/0960-0760(92)90439-p&quot;>10.1016/0960-0760(92)90439-p</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1562563/&quot;>https://pubmed.ncbi.nlm.nih.gov/1562563</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A11CC02;
